相关实验视频
Updated: Jul 19, 2025

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
35.8K
由E2F1驱动的基因组脱甲基酶KDM6B通过操纵TFEB依赖的自轴增强甲状腺恶性瘤
Xiaoyuan Wang1, Chi Zhang1, Na Dong2
1Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, Jiangsu, China.
Experimental cell research
|August 13, 2023
概括
基因素脱甲基酶KDM6B通过调节自而驱动甲状腺癌 (THCA) 的进展. 针对KDM6B或自为THCA提供了潜在的新疗法.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子瘤学分子瘤学
- 细胞生物学 细胞生物学
背景情况:
- 异常的表观遗传修饰会影响瘤的进展.
- 目前尚不清楚基因组脱甲基酶KDM6B在甲状腺癌 (THCA) 中的作用.
研究的目的:
- 研究KDM6B在THCA中的作用和机制.
- 探索KDM6B作为THCA的潜在治疗点.
主要方法:
- 用于查和验证的MTT测定.
- 在体外和体内测试的扩散,迁移和入侵.
- 染色体免疫沉 (ChIP) 和西式涂抹用于分析蛋白质相互作用和修饰.
主要成果:
- KDM6B促进THCA的扩散,迁移和入侵.
- E2F1直接调节KDM6B的表达,而KDM6B部分调节E2F1的致癌功能.
- 在TFEB促进物处KDM6B去甲基化H3K27me3,激活TFEB和下游 lysosomal基因,从而增强自.
- KDM6B增强了自 (由p62和Beclin-1证明) 并加速了THCA的进展.
- 用3-MA向自显著抑制KDM6B高THCA生长.
结论:
- 在THCA中,KDM6B是必不可少的表观遗传调节剂和自促进剂.
- E2F1/KDM6B/TFEB轴代表了THCA治疗的新型治疗脆弱性.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Synthesis and Regulation of Thyroid Hormones
4.7K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K

